Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens
Condition(s):Carcinoma, Renal CellLast Updated:May 1, 2009Completed
Hide Studies Not Open or Pending
Condition(s):Carcinoma, Renal CellLast Updated:May 1, 2009Completed
Condition(s):Adverse Effects in the Therapeutic Use of InterferonLast Updated:August 28, 2013Unknown status
Condition(s):MelanomaLast Updated:February 28, 2014Completed
Condition(s):CandidemiaLast Updated:November 3, 2023Recruiting
Condition(s):Self Efficacy; Hepatitis CLast Updated:April 4, 2011Unknown status
Condition(s):Retinal Disease; Macular DiseaseLast Updated:January 30, 2024Completed
Condition(s):Chronic Pulmonary Aspergillosis; AspergillosisLast Updated:October 30, 2023Not yet recruiting
Condition(s):CancerLast Updated:July 25, 2014Terminated
Condition(s):Hepatitis C, Chronic; Liver Diseases; Interferon DeficiencyLast Updated:January 4, 2013Unknown status
Condition(s):Chronic Myelogenous LeukemiaLast Updated:August 12, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.